Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.45
+0.40 (1.38%)
At close: May 8, 2026
Market Cap2.13B +78.5%
Revenue (ttm)708.38M +36.9%
Net Income-39.43M
EPS-0.54
Shares Out72.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume851,617
Average Volume1,071,891
Open29.05
Previous Close29.05
Day's Range28.00 - 30.15
52-Week Range17.90 - 36.85
Beta0.13
RSI53.47
Earnings DateAug 7, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. The company was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 36.86% compared to the previous year's 517.58 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements